©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Introduction of Selectin-like Binding Specificity into a Homologous Mannose-binding Protein (*)

(Received for publication, January 17, 1996; and in revised form, January 30, 1996)

Olivier Blanck (1)(§) Susanne T. Iobst (1)(¶) Christopher Gabel (2) Kurt Drickamer (1)(**)

From the  (1)Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York 10032 and (2)Department of Cancer, Immunology, and Infectious Diseases, Pfizer Central Research, Groton, Connecticut 06340

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The structures of the ligand-binding C-type carbohydrate-recognition domains of selectin cell adhesion molecules and of mannose-binding proteins (MBPs) are similar to each other even though these proteins bind very different carbohydrate ligands. Our current understanding of ligand binding by E-selectin is based on structural studies of unliganded E-selectin and of MBP-carbohydrate complexes, combined with results from mutagenesis of E-selectin. Five regions of E-selectin that differ in sequence from the corresponding regions of MBP have been introduced into the carbohydrate-recognition domain of MBP. Four of the changes have little effect on ligand binding. Insertion of one stretch of positively charged amino acids alters the sugar binding selectivity of the domain so that it now binds HL-60 cells and serum albumin derivatized with sialyl-Lewis^x tetrasaccharide, thus mimicking the properties of E-selectin.


INTRODUCTION

One of the most striking properties of animal proteins that contain Ca-dependent carbohydrate-recognition domains (C-type CRDs) (^1)is the diversity of sugar ligands that bind to different members of this family(1) . In broad terms, these CRDs fall into two classes. CRDs in one class bind ligands containing galactose or N-acetylgalactosamine with varying degrees of selectivity and affinity. CRDs in the second class bind to mannose and/or N-acetylglucosamine. The distinguishing feature of the ligands for these two classes is the disposition of the 3- and 4-hydroxyl groups. The results of structural and mutagenesis studies suggest that in all C-type lectins these hydroxyl groups form part of the coordination sphere of a bound Ca(2, 3, 4) . Preferential binding of sugars with an equatorial-axial or equatorial-equatorial arrangement at positions 3 and 4 is determined by the arrangement of side chains from the protein that form both coordination bonds with the Ca and hydrogen bonds with the sugar hydroxyl groups. L-Fucose binds to CRDs in the second class through analogous interactions of the equatorial 2- and 3-hydroxyl groups. Increased affinity and selectivity for certain sugars within each of the two classes of C-type CRDs results from other contacts between the protein and the sugar. For example, selective binding of N-acetylgalactosamine over galactose by the asialoglycoprotein receptor requires the presence of additional amino acid residues that are probably positioned near the 2-acetamido group(5) .

High affinity binding of C-type animal lectins to complex sugar ligands results from at least two additional effects. Clustering of multiple CRDs, each with a single sugar-binding site displayed in an appropriate geometrical arrangement, results in high affinity binding of multiantennary sugars(6) . In mannose-binding proteins (MBPs), such clustering results from oligomerization of polypeptides containing single CRDs(7) , while there are duplicated CRDs in the single polypeptide of the macrophage mannose receptor(8) . Alternatively, additional affinity and selectivity can reflect the presence of secondary or extended binding sites within single CRDs. In these cases, a single CRD can interact with more than a single sugar in an oligosaccharide. Liver MBP (MBP-C) but not serum MBP (MBP-A) appears to contain such a secondary site. (^2)

Selectin cell adhesion molecules mediate the interaction of circulating leukocytes with vascular endothelial cells, initiating a transient rolling that eventually leads to firmer attachment and extravasation (9, 10) . E- and P-selectins are found at the surface of epithelial cells and interact with monocytes and neutrophils, while L-selectin is expressed on circulating leukocytes and selectively recognizes the surface of high endothelial venules of the peripheral lymph nodes. Each of the selectins consists of an NH(2)-terminal C-type CRD adjacent to an epidermal growth factor-like domain and a series of complement homology modules(9, 10) . The natural ligands for the selectins are not known, but fucose-containing oligosaccharides are the most effective low molecular weight ligands. The tetrasaccharide sialyl-Lewis^x(9) and various sulfated derivatives (11) have been studied most extensively. Recent evidence suggests that, in addition to clusters of such oligosaccharide ligands, high affinity glycoprotein ligands for P-selectin bear sulfated tyrosine residues (12, 13, 14) .

The structure of a fragment of human E-selectin consisting of the CRD and epidermal growth factor-like domains has been established by x-ray crystallography(15) . This structure reveals a single Ca-binding site, in contrast to the two sites observed in the MBP-A and MBP-C CRDs(2, 3) . Evidence from binding studies suggests first order dependence on Ca concentration, consistent with the presence of a single Ca-binding site(16) . In the absence of structural information about the sugar-binding sites in the selectins, mutagenesis studies and modeling based on the MBP-A-oligomannose and MBP-C-monosaccharide structures have been combined to suggest possible modes of interaction of E-selectin (16, 17, 18) and P-selectin (19, 20, 21, 22) with sialyl-Lewis^x. The fucose moiety of the ligand probably binds directly to the single Ca and surrounding amino acid residues in the E-selectin CRD in a manner analogous to the interactions of mannose with Ca site 2 of MBP-A (2) and of fucose and other sugars with Ca site 2 of MBP-C(3) , while negatively charged portions of the ligands are believed to interact with one or more regions of positive potential on adjacent portions of the CRD surface (16, 17, 18, 19, 20, 21, 22) .

In the present studies, segments of E-selectin have been substituted into the MBP-A CRD. Replacement of a single segment of 3 amino acid residues confers upon the CRD the ability to bind HL-60 cells and sialyl-Lewis^x-BSA. While many previous experiments have relied on negative phenotypes of mutants in the E-selectin CRD to identify functionally important residues, these experiments provide positive evidence for the importance of a second portion of the CRD surface in addition to the region directly surrounding Ca site 2.


EXPERIMENTAL PROCEDURES

Materials

Materials for construction of mutated expression plasmids, protein preparation, and solid phase binding assays have been previously described(23) . Man-BSA was purchased from EY Laboratories, and sialyl-Le^x-BSA containing 12.6 mol of tetrasaccharide/mol of BSA was purchased from Oxford Glycosystems. Cell culture medium was obtained from Life Technologies, Inc. Tritiated thymidine was purchased from Amersham Corp. Scintillation fluid was a product of Packard Instruments. The soluble extracellular domain of E-selectin produced in Chinese hamster ovary cells was a gift of Pfizer Central Research.

Mutation of MBP-A

Mutations were introduced into the wild type MBP-A cDNA (24) by replacing short restriction fragments with pairs of synthetic oligonucleotides following standard recombinant DNA techniques(25) . Mutations were created in a SacI to BamHI fragment coding for the COOH-terminal 92 amino acids of the CRD. Within this fragment, the following substitutions were made. In region 1, the segment starting at base 80 (numbered from the 5` end of the SacI site) and flanked by AvrII and NlaIII sites was replaced with the sequence CCTAGGCATCAGGAAGGTCAACAACGTCTTCATG. In region 2, the segment starting at base 166 and flanked by BanII and BbsI sites was replaced with the sequence GAGCCCAATAATCGACAGAAGGACGAAGACTGTGTC. In region 3, the segment starting at base 53 and flanked by XcmI and AvrII sites was replaced with the sequence CCAAGAAGTGGCTAGCTACTCTCCCTCTTACGCCTTCCTAGG. In region 4, the segment starting at base 190 and flanked by BbsI and AccI sites was replaced with the sequence GAAGACTGTGTCACTATATACATCAAGCGCGAGAAAGAC. In region 5, the segment starting at base 242 and flanked by HindIII and Bsu36I sites was replaced with the sequence GAAGAAGAAGACGGCTGTCTGCGAGTTCCCAGCCTGAGG following trimming of the 5` overhang at the HindIII site with mung bean nuclease.

Production of Wild Type and Mutant CRDs

CRDs were prepared as described for the wild type CRD (26) or by induction in the presence of Ca followed by direct purification by affinity chromatography(27) .

Binding Assays

Competition and direct binding assays, in which wild type and mutant CRDs were immobilized on polystyrene wells, were performed and analyzed as described previously(27) , using I-Man-BSA and I-sialyl-Lewis^x-BSA as test ligands. Plates prepared in the same manner were used for binding assays using tritium-labeled HL-60 cells. HL-60 cells (10^7) were grown in 10 ml of RPMI 1640 medium containing 10% fetal calf serum and 100 µCi of [^3H]thymidine. After incubation overnight, the cells were collected by centrifugation and washed twice with binding buffer (0.125 M NaCl, 1 mM CaCl(2), 1 mM MgCl(2), 10 mM HEPES, pH 7.0, and 1 mg/ml BSA) and resuspended in 6 ml of binding buffer. Wells coated with CRDs and blocked with BSA were filled with 50 µl of binding buffer with or without addition of EDTA to a final concentration of 5 mM, followed by 50 µl of cell suspension. After incubation for 15 min at room temperature (no shaking), the cells were aspirated off, and the wells were rinsed three times with 200 µl/well binding buffer. Bound cells were transferred to glass vials after solubilization with two rinses of 150 µl of 2% Triton X-100 in 100 mM sodium carbonate, pH 8.5. Glacial acetic acid (50 µl) and scintillation fluid (2 ml) were added, and radioactivity was measured on an LKB RackBeta scintillation counter.


RESULTS AND DISCUSSION

Five segments of E-selectin were incorporated into the MBP-A framework. Two of the regions were hypothesized to be involved in Ca ligation, while there is evidence that the other three may be directly associated with oligosaccharide binding.

Modification of Ca-binding Sites

Comparison of the structures of the MBP-A and E-selectin CRDs reveals that the position of one of the two Ca sites in MBP-A (Fig. 1, site 2) corresponds closely to the single Ca site in E-selectin(15) . The presence of a single functional Ca-binding site in E-selectin has been confirmed by biochemical analysis(16) . Although 1 of the 5 amino acid side chains that ligate this Ca differs between the two CRDs, the other 4 liganding amino acids are located at exactly corresponding positions in the two amino acid sequences (Fig. 2) and form sites with very similar geometry. In contrast, most of the amino acid side chains in MBP-A that form Ca site 1 have been nonconservatively substituted in E-selectin so that this portion of the polypeptide is arranged in a substantially different way than in MBP-A.


Figure 1: Location of mutated regions of MBP-A on the three-dimensional structure of the CRD. The structure of wild type MBP-A CRD is shown as a ribbon diagram. Spheres labeled 1 and 2 represent Ca sites 1 and 2, respectively. Regions 1-5, which have been substituted by sequences from E-selectin, are highlighted by dark shading and are labeled R1-R5. Regions 1 and 2 contribute side chain ligands to Ca site 1, while point mutations in the portions of the E-selectin CRD corresponding to regions 3-5 affect binding to HL-60 cells. The figure was prepared using MOLSCRIPT (28) .




Figure 2: Amino acid sequences of the COOH-terminal portions of wild type MBP-A and E-selectin and mutants of MBP-A containing E-selectin sequences. The positions of amino acids that ligate Ca sites 1 and 2 are designated below the sequence of MBP-A. The positions of mutations that have previously been found to affect the binding activity of E-selectin are indicated above the sequence of E-selectin. Phenotypes are denoted as - for complete loss of binding activity and ± for partial loss of activity. Data are summarized from (16, 17, 18) .



In order to probe which of the amino acid substitutions might be responsible for the absence of Ca site 1 in E-selectin, two segments of polypeptide that contribute ligands for this Ca in MBP-A were replaced with the corresponding regions of E-selectin. These segments are designated regions 1 and 2 in Fig. 1. The mutant CRDs containing changes in regions 1 and 2 were prepared in a bacterial expression system previously used for analysis of wild type MBP-A CRD. Interaction of the mutant CRDs with Ca was analyzed by measuring the Ca dependence of ligand binding in a solid phase assay (Fig. 3). As indicated by the shape of the curves, both mutant CRDs retain second order dependence on Ca, indicating that two Ca-binding sites are still present. The measured K for the region 1 mutant (2.8 ± 0.3 mM) is substantially weaker than for the region 2 mutant (1.4 ± 0.1 mM) and wild type (1.2 ± 0.1 mM(26) ).


Figure 3: Ca dependence of ligand binding to mutant MBP-A CRDs. Ca was diluted in 1.5-fold increments. Curves were fitted to second-order Ca binding equations(26) .



The second order dependence on Ca was confirmed for the region 2 mutant using limited proteolysis with subtilisin to detect a Ca-dependent conformational change similar to that observed for the wild type CRD (26) (data not shown). This assay could not be utilized in the case of the region 1 mutant, because this CRD proved resistant to proteolysis even in the absence of Ca, probably because the initial protease-sensitive site detected in these assays lies within the loop that has been substituted.

As shown in Fig. 2, substitution of region 2 of E-selectin into MBP-A results in a change of one Ca site 1 coordination ligand from aspartic acid to asparagine, while the substitution of region 1 results in more substantial changes, as a stretch of 8 amino acid residues including one aspartic acid and one glutamic acid ligand is replaced with a shorter sequence of 6 residues containing lysine and asparagine residues at the corresponding positions. These results indicate that Ca-binding site 1 is not significantly affected by substitution of region 2, while it is preserved but weakened by substitution of region 1. The fact that the Ca dependence of sugar binding to the region 1 mutant remains second order indicates that both sites 1 and 2 must be occupied in order to create a sugar-binding site. The absolute affinity of both region 1 and region 2 mutants for Man-BSA is unchanged from wild type (data not shown). Thus, although substitution of residues in region 1 reduces the affinity of this site for Ca and thus increases the overall K, the ultimate conformation achieved is not distinguishable from that of the wild type CRD.

Like the region 1 and region 2 mutants, a double mutant containing both region 1 and region 2 substitutions was produced in the bacterial expression system in yields comparable with wild type. However, unlike the single mutants, the double mutant could not be purified by affinity chromatography on Man-Sepharose. It is likely that the presence of both regions 1 and 2 in the MBP-A background reduces the affinity of site 1 for Ca much more than does either region alone, so a conformation like the doubly Ca-ligated form of MBP-A is not stable even at 25 mM Ca. It is possible that the presence of regions 1 and 2 from E-selectin is not sufficient to induce the alternative stable conformation seen in E-selectin in the absence of Ca site 1, and thus the double mutant does not fold correctly. However, since E-selectin itself does not bind to Man-Sepharose, if the conformation of MBP-A containing both regions 1 and 2 from E-selectin does fold similarly to E-selectin, it might still not bind to Man-Sepharose. Unfortunately, since it was not possible to purify the mutant CRD containing both region 1 and 2 substitutions in soluble form, binding to HL-60 cells or known oligosaccharide ligands for E-selectin could not be tested.

Binding to HL-60 Cells

A common feature of the best ligands for E-selectin is the presence of a fucose residue(9) . It is believed that the 2- and 3-hydroxyl groups of fucose may ligate the Ca bound to the CRD in a manner analogous to the way that the 3- and 4-hydroxyl groups of mannose interact with Ca site 2 of MBP-A(2) . Results of mutagenesis targeted at residues near the Ca-binding site of E-selectin are consistent with this suggestion(15, 18) . One possible orientation of fucose ligated in this manner in a complex between the homologous MBP-C CRD and alpha-methyl fucoside has been analyzed crystallographically(3) . Extensive mutagenesis studies of the selectins have led to the identification of three additional regions of the CRD that might be involved in interactions with other sugar residues in the sialyl-Lewis^x ligand (regions 3, 4, and 5 in Fig. 1and 2). Regions 4 and 5 contain several basic amino acid side chains that could interact with the charged sialic acid residue or with sulfates attached to related oligosaccharide ligands. The importance of positively charged residues in region 5 of the P-selectin CRD has recently been demonstrated by chemical modification studies, in which the first and third lysine residues in this region have been replaced by various charged and uncharged derivatives of cysteine(22) .

As an alternative approach to evaluating the role of regions 3, 4, and 5, each of these segments of E-selectin has been substituted into the MBP-A background. All three of the modified MBP-A CRDs can be purified by affinity chromatography on mannose-Sepharose, suggesting that their ability to bind mannose is not substantially diminished by the substitutions. The ability to bind HL-60 cells was utilized to determine if these CRDs have E-selectin-like binding characteristics. As shown in Fig. 4, only the region 5 mutant displays Ca-dependent binding to HL-60 cells. CRDs containing region 5 in combination with either region 3 or region 4 were purified and found to have binding characteristics indistinguishable from those of the region 5 mutant alone (data not shown). These results provide positive evidence that the cluster of basic residues in region 5 plays a role in binding of HL-60 surface ligands. Since wild type MBP-A does not bind HL-60 cells, this binding must reflect a novel activity induced by the presence of region 5.


Figure 4: HL-60 binding to wild type MBP-A and E-selectin and mutants of MBP-A containing E-selectin sequences. Binding experiments were performed in triplicate, with the results of five separate experiments averaged, except in the case of region 3 and 4 mutants, which are the average of two experiments. Error bars represent standard deviations. Results are shown for binding in the presence of 10 mM Ca (+Ca) or in the presence of 1 mM EDTA (-Ca).



The nature of the binding activity of the region 5 mutant was investigated further by testing the ability of this mutant to bind to sialyl-Lewis^x conjugated to BSA. The iodinated ligand was bound substantially more effectively to plates coated with the region 5 mutant than to wild type mannose-binding protein (Fig. 5). Because of the limited quantities of the neoglycoprotein ligand available, it was not possible to achieve saturation of binding, so an accurate dissociation constant could not be determined. However, the results in Fig. 5suggest that incorporation of region 5 results in a substantial increase in affinity for the sialyl-Lewis^x structure. Parallel experiments with I-Man-BSA show no change in affinity for this ligand, indicating that the increase in affinity is specific for the sialylated structures (data not shown).


Figure 5: Solid-phase binding assays wild type and mutant MBP-A probed with I-sialyl-Lewis^x-BSA. Experimental data (filled circles) are shown along with theoretical curves (continuous lines) fitted to the data.



The fact that binding to sialyl-Lewis^x-BSA can be observed in the simple solid phase assay with the region 5 mutant, while it is difficult to demonstrate with natural E-selectin may reflect the trimeric nature of the MBP-A derivative(7) . The relatively close clustering of the three binding sites in the trimer probably increases the affinity for the polyvalent test ligand. This result suggests that formation of similar clusters of the E-selectin CRD may be a useful way to increase the affinity of the natural CRD in order to simplify measurement of ligand binding.

Conclusions

In the absence of direct structural information about the mode of sialylated, fucosylated ligand binding to E-selectin, negative mutagenesis data have been the primary source of enlightenment about likely sites of interaction with the sugar ligand. Extensive studies of this type have defined three regions that appear to mediate binding to ligands such as sialyl-Lewis^x. The most definitive phenotypes are associated with changes in tyrosine and arginine residues in region 4 and one of the three lysine residues in region 5 (Fig. 2(16, 17, 18) ). The importance of amino groups in region 5 has been further demonstrated using chemical modification(22) . A caveat of such studies is the concern that changes distant from the binding site might cause a decrease in affinity for ligand by indirectly affecting the actual binding site, so the negative phenotype cannot be taken to prove direct interaction with ligand. The present studies extend these results by providing positive evidence that inclusion of one of the regions identified by negative mutagenesis can generate specificity for the sialyl-Lewis^x epitope. While it cannot be stated with certainty that the mode of ligand binding to the region 5 mutant is the same as the mode of binding to E-selectin, analysis of the region 5 mutant complexed with sialyl-Lewis^x may provide insight into the possible ways that the selectins bind to their ligands.


FOOTNOTES

*
This work was supported by a grant from Pfizer Central Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Present address: Laboratoire de Biochimie, University d'Aix Marseille II, Faculte de Medecine, Secteur Nord, Boulevard Pierre Dramard 13916, Marseille Cedex 20, France.

Supported by Unilever Research US Inc. Present address: Unilever Research US Inc., 45 River Rd., Edgewater, NJ 07020.

**
To whom correspondence should be addressed: Dept. of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK. Tel.: 44-1865-275727; Fax: 44-1865-275339.

(^1)
The abbreviations used are: CRD, carbohydrate-recognition domain; MBP, mannose-binding protein; BSA, bovine serum albumin.

(^2)
M. S. Quesenberry, R. T. Lee, E. Freire, and Y. C. Lee, personal communication.


ACKNOWLEDGEMENTS

We thank Nydia Ruiz and Dawn Torgersen for assistance with some of the experiments, William Weis for help in the preparation of Fig. 1, and Maureen Taylor, William Weis, and Russell Wallis for comments on the manuscript.


REFERENCES

  1. Drickamer, K., and Taylor, M. E. (1993) Annu. Rev. Cell Biol. 9, 237-264 [CrossRef]
  2. Weis, W. I., Drickamer, K., and Hendrickson, W. A. (1992) Nature 360, 127-134 [CrossRef][Medline] [Order article via Infotrieve]
  3. Ng, K. K.-S., Drickamer, K., and Weis, W. I. (1996) J. Biol. Chem. 271, 663-674 [Abstract/Free Full Text]
  4. Kolatkar, A., and Weis, W. I. (1996) J. Biol. Chem. 271, 6679-6685 [Abstract/Free Full Text]
  5. Iobst, S. T., and Drickamer, K. (1996) J. Biol. Chem. 271, 6686-6693 [Abstract/Free Full Text]
  6. Weis, W. I., and Drickamer, K. (1996) Annu. Rev. Biochem. 65, in press
  7. Weis, W. I., and Drickamer, K. (1994) Structure 2, 1227-1240 [Medline] [Order article via Infotrieve]
  8. Taylor, M. E., and Drickamer, K. (1993) J. Biol. Chem. 268, 399-404 [Abstract/Free Full Text]
  9. Rosen, S. D., and Bertozzi, C. R. (1994) Curr. Opin. Struct. Biol. 6, 663-673 [CrossRef]
  10. McEver, R. P. (1994) Curr. Opin. Immunol. 6, 75-84 [CrossRef][Medline] [Order article via Infotrieve]
  11. Hemmerich, S., Leffler, H., and Rosen, S. D. (1995) J. Biol. Chem. 270, 12035-12047 [Abstract/Free Full Text]
  12. Wilkins, P. P., Moore, K. L., McEver, R. P., and Cummings, R. D. (1995) J. Biol. Chem. 270, 22677-22680 [Abstract/Free Full Text]
  13. Sako, D., Comess, K. M., Barone, K. M., Camphausen, R. T., Cumming, D. A., and Shaw, G. D. (1995) Cell 83, 323-331 [Medline] [Order article via Infotrieve]
  14. Pouyani, T., and Seed, B. (1995) Cell 83, 333-343 [Medline] [Order article via Infotrieve]
  15. Graves, B. J., Crowther, R. L., Chandran, C., Rumberger, J. M., Li, S., Huang, K.-S., Presky, D. H., Familletti, P. C., Wolitzky, B. A., and Burns, D. K. (1994) Nature 367, 532-538 [CrossRef][Medline] [Order article via Infotrieve]
  16. Anostario, M. J., and Huang, K.-S. (1995) J. Biol. Chem. 270, 8138-8144 [Abstract/Free Full Text]
  17. Erbe, D. V., Wolitzky, B. A., Presta, L. G., Norton, C. R., Ramos, R. J., Burns, D. K., Rumberger, J. M., Rao, B. N. N., Foxall, C., Brandley, B. K., and Lasky, L. A. (1992) J. Cell Biol. 119, 215-227 [Abstract]
  18. Kogan, T. P., Revelle, B. M., Tapp, S., Scott, D., and Beck, P. J. (1995) J. Biol. Chem. 270, 14047-14055 [Abstract/Free Full Text]
  19. Erbe, D. V., Watson, S. R., Presta, L. G., Wolitzky, B. A., Foxall, C., Brandley, B. K., and Lasky, L. A. (1993) J. Cell Biol. 120, 1227-1235 [Abstract]
  20. Hollenbaugh, D., Bajorath, J., Stenkamp, R., and Aruffo, A. (1993) Biochemistry 32, 2960-2966 [Medline] [Order article via Infotrieve]
  21. Bajorath, J., Hollenbaugh, D., King, G., Harte, W., Jr., Eustice, D. C., Darveau, R. P., and Aruffo, A. (1994) Biochemistry 33, 1332-1339 [Medline] [Order article via Infotrieve]
  22. Hollenbaugh, D., Aruffo, A., and Senter, P. D. (1995) Biochemistry 34, 5678-5684 [Medline] [Order article via Infotrieve]
  23. Iobst, S. T., Wormald, M. R., Weis, W. I., Dwek, R. A., and Drickamer, K. (1994) J. Biol. Chem. 269, 15505-15511 [Abstract/Free Full Text]
  24. Drickamer, K., Dordal, M. S., and Reynolds, L. (1986) J. Biol. Chem. 261, 1034-1046
  25. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  26. Weis, W. I., Crichlow, G. V., Murthy, H. M. K., Hendrickson, W. A., and Drickamer, K. (1991) J. Biol. Chem. 266, 20678-20686 [Abstract/Free Full Text]
  27. Quesenberry, M. S., and Drickamer, K. (1992) J. Biol. Chem. 267, 10831-10841 [Abstract/Free Full Text]
  28. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950 [CrossRef]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.